FLUAD Quad - the influenza vaccine with MF59® Adjuvant

FLUAD® Quad is an adjuvanted seasonal influenza vaccine for adults 65 years and older.1

Adding an adjuvant to the influenza vaccine enhances the antibody response to the antigens in the vaccine,1,2 by:

  • increasing the magnitude of the antibody response by stimulating more immune cells to create more antibodies1-4*
  • broadening the antibody response by creating higher levels of cross-reactive antibodies.1-4*

FLUAD Quad is distributed by CSL Seqirus, a world leader in the development of influenza vaccines and the supplier of the funded seasonal influenza vaccine in New Zealand.

*compared to non-adjuvanted, standard dose influenza vaccines 

References: 1. Seqirus NZ. FLUAD Quad Data Sheet. Seqirus (NZ) Ltd. November 2022. 2. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine. 2001;19(17-19):2673-2680. 3. Di Pasquale A, Preiss S, Tavares Da Silva F, Garcon N. Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccines (Basel). 2015;3(2):320-343. 4. Garçon N, Leroux-Roels G, Cheng WF. Vaccine adjuvants. Understanding Modern Vaccines: Perspectives in Vaccinology. 2011;1(1):89-113.